We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FDA Says Ranbaxy Falsified Data From India Plant

Law360 (February 25, 2009, 12:00 AM EST) -- The U.S. Food and Drug Administration has accused a Ranbaxy Laboratories Ltd. facility in India of submitting false information and test results for certain approved drugs and pending drug applications.

The agency said Wednesday it has halted its review of any new or pending drug approval applications with data generated from the Ranbaxy plant in Paonto Sahib and asked the facility to submit a correction action plan to address concerns with integrity of its data.

The action relates only to the Paonto Sahib facility. It applies...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.